Ticagrelor Administered as Standard Tablet or orodispersiblE foRmulation
Latest Information Update: 04 Nov 2021
Price :
$35 *
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Registrational; Therapeutic Use
- Acronyms TASTER
- 12 Aug 2021 Status changed from recruiting to completed.
- 01 Sep 2020 Results (n=65) assessing the superiority in platelet inhibition with 180 mg Ticagrelor loading dose (LD) administered as ODT as compared with standard (coated table) Ticagrelor formulation, among 130 ACS patients undergoing PCI, presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology.
- 03 Jul 2019 Status changed from not yet recruiting to recruiting.